近日,来自华东师范大学的研究者们在Int. J. Biol. Sci.杂志上发表了题为“Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer”的文章,该研究表明靶向BCL6可能是治疗卵巢癌的有效途径,WK369具有作为卵巢癌候选治疗剂的潜力。
Min Wu et al. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer. Int J Biol Sci. 2024 Jan 1;20(2):486-501. doi: 10.7150/ijbs.86303.